Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01026_DB01198_nanopub.RAemzeq5_7-N8ece_fwJxOo13BEAikRNb5av0i94Ft13E#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01026_DB01198 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01026_DB01198 label "DDI between Ketoconazole and Zopiclone - Ketonconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if ketoconazole is initiated, discontinued or dose changed. [drugbank_resource:DB01026_DB01198]" assertion.
- drugbank_resource:DB01026_DB01198 identifier "drugbank_resource:DB01026_DB01198" assertion.
- drugbank_resource:DB01026_DB01198 title "DDI between Ketoconazole and Zopiclone - Ketonconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if ketoconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB01198 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01026_DB01198 assertion.
- drugbank:DB01026 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01026_DB01198 assertion.